MIAMI, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for breast cancer and for viral acute respiratory distress syndrome (ARDS), today announced it will host a conference call and audio webcast on Thursday, August 10, 2023,…Read More
Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10 2023
